Paradigm Biocapital Advisors LP 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:34 pm Sale | 2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm Biocapital Advisors LP | 5,503,600 9.600% | -2,400,000 (-30.37%) | Filing |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm Biocapital Advisors LP | 7,903,600 14.300% | 100,000 (+1.28%) | Filing |
| 2023-09-13 5:22 pm Purchase | 2023-09-12 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm Biocapital Advisors LP | 7,803,600 14.300% | 5,288,489 (+210.27%) | Filing |
| 2023-04-10 4:33 pm Purchase | 2023-03-29 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm Biocapital Advisors LP | 2,515,111 6.200% | 2,515,111 (New Position) | Filing |